Showing results (901-910 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|February 7, 2018
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trialChristine L Baker, Guilhem PietriClinicoeconomics and Outcomes Research : CEOR|January 4, 2018
Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapyJulia Zhu, Heather S Kirkham, Gretchen Ayer, et al.Clinicoeconomics and Outcomes Research : CEOR|January 19, 2018
Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasiaJames C Ulchaker, Melissa S MartinsonClinicoeconomics and Outcomes Research : CEOR|February 9, 2018
The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysisGiorgio L Colombo, Sergio Di Matteo, Chiara Martinotti, et al.Clinicoeconomics and Outcomes Research : CEOR|December 28, 2018
Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settingsJeffrey Trocio, Virginia M Rosen, Anu Gupta, et al.Clinicoeconomics and Outcomes Research : CEOR|March 29, 2018
Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in MalaysiaTamlyn Anne Rautenberg, Ute Zerwes, Way Seah LeeClinicoeconomics and Outcomes Research : CEOR|March 29, 2018
Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspectiveScott J Luhmann, Eoin M McAughey, Stacey J Ackerman, et al.Clinicoeconomics and Outcomes Research : CEOR|February 5, 2013
Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapyAnagha Nadkarni, Iftekhar Kalsekar, Min You, et al.Clinicoeconomics and Outcomes Research : CEOR|February 16, 2013
Cost-effectiveness evaluation of escitalopram in major depressive disorder in ItalyClaudio Mencacci, Guido Di Sciascio, Pablo Katz, et al.Clinicoeconomics and Outcomes Research : CEOR|September 5, 2013
Early enteral nutrition in critical illness: a full economic analysis using US costsGordon S Doig, Hélène Chevrou-Séverac, Fiona SimpsonPageof 102